Drawing for ACINO

USPTO serial 86884779

ACINO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TOY, JOSHUA SPENCER JOLL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACINO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William J. Seiter

WILLIAM J. SEITER Seiter Legal Studio2500 Broadway, Bldg F, Suite F-125Santa Monica, CA 90404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases, neoplasms, diseases of blood or blood-forming organs or disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases or disorders; Pharmaceutical products and preparations for the prevention and treatment of mental or behavioral disorders in the nature of diseases of the nervous system, neurological diseases and disorders, and neurodegenerative diseases and disorders; Pharmaceutical products and preparations for the prevention and treatment of diseases of the eye or adnexa, diseases of the ear or mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin or subcutaneous tissue; Pharmaceutical products and preparations for the prevention and treatment of diseases of the musculoskeletal system or connective tissue in the nature of diseases of the genitourinary system, and congenital malformations, deformations or chromosomal abnormalities; Pharmaceutical products and preparations for fertility in the nature of fertility enhancement preparations, birth control in the nature of contraceptive preparations, anesthetic for surgical purposes for use in and child birth and during puerperium; Pharmaceutical products and preparations for treating wounds and poisoning; Pharmaceuticals and pharmaceutical preparations in the nature of antibacterial pharmaceuticals for protection against bacterial agents resistant to antibiotics; Pharmaceutical products and preparations for the prevention and treatment of pain and neuropathic painACTIVE—
042Scientific and technological services and research and design relating thereto, namely, pharmaceutical research and development servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 10, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 10, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 26, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2017EX2GSOU EXTENSION 2 GRANTED—
Oct 24, 2017EXT2SOU EXTENSION 2 FILED—
Oct 24, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 18, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2017EX1GSOU EXTENSION 1 GRANTED—
Feb 16, 2017EXT1SOU EXTENSION 1 FILED—
Feb 16, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 4, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 27, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 27, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Oct 27, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 27, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 27, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2016ALIEASSIGNED TO LIE—
Oct 12, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2016DOCKASSIGNED TO EXAMINER—
Mar 26, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 30, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 29, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 27, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance